Hologen-preview

Hologen

Private

United KingdomHealthcare & Life Scienceshttps://hologen.ai

Last Round

Series A

Jan 28, 2026

Momentum Score

50 /100

Company Overview

Hologen is an AI biotech company that develops multi-modal generative AI models to improve the understanding, design, evaluation, and delivery of treatments for neurological and other complex health conditions.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Medical AI, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Foundation

Keywords

large medical modelLMMAI drug discoverygenerative AImulti-modal AIclinical trial analysisbiology foundation modeldrug development partnershipstherapeutic developmentmedical AICNS drug developmentcentral nervous systemCNSgenetic medicinejoint venture model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hologen Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Hologen Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jan 28, 2026
VC Round	Jul 1, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

Chris Goddard

CTO Co-founder

Founding Team

M. Jorge Cardoso

Co-Founder Chief AI Officer

Founding Team

Dean Worrall

Chief Financial Officer

Executive Team

Hologen Investors

Notable investors and investment history

Investor	Rounds
2468 Ventures	VC Round
UCL Business	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 27, 2026
Grew 36% QoQ, from 25 to 34 employees.
May 17, 2026
Monthly visitors increased 39% MoM, reaching 4K.

View all signals

Hologen Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Hologen Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hologen's valuation, stock price, and market status.

Firmographic Details

HeadquartersUnited Kingdom

Employee Range34

Year Founded2023

Last FundingJan 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.